AJMALINE - Watsons Health

AJMALINE

Ajmaline is a drug that is from the root of a plant named Rauwolfia serpentine. It is being used to treat disturbances of heart rate and rhythm by changing and normalizing action potentials in the heart. The drug blocks sodium channels in heart cells though it has a very short half-life. This drug is often given as an injection.

Ajmalin is used in the treatment of abnormal heart rate and rhythm such as atrial fibrillation. This is also used to test for a heart condition known as Brugada syndrome.

Ajmaline is considered to be safe in general. However, there may be risks especially if you have other concomitant diseases that will be explained by your doctor.

Complications that may arise from the use of this drug are very rare.

Ajmaline may bring about side effects such as the following:

  • Metallic taste in the mouth
  • Blurring of vision
  • Fast heart rate
  • Very slow heart rate

Precautions

Tell your doctor is you have other heart problems before using this medication.

 

Interactions

Ajmaline may interact with the following medicines:

  • Amiodarone
  • Bupropion
  • Celecoxib
  • Chloroquine
  • Chlorpromazine
  • Cimetidine
  • Clomipramine
  • Clotrimazole
  • Clozapine
  • Cocaine
  • Diphenhydramine
  • Fluoxetine
  • Haloperidol
  • Isoniazid
  • Ketoconazole
  • Metoprolol
  • Ranolazine

Signs of overdose include blurring of vision, very fast heart rate or very slow heart rate. If you think you have used Ajmaline more than what is intended for you, seek medical help immediately.

Available Brand/s:

Ritmos, Gilurytmal, Aritmina

Related Articles

DTP-HIB Vaccine

DTP-HIB vaccine is a combined vaccine of adsorbed diphtheria, tetanus toxoid and acellular pertussis and of Haemophilus influenzae type b conjugate vaccines. It is a [...]

Tenecteplase

Tenecteplase is a tissue-type plasminogen activator (tPA), a biosynthetic form of human enzyme that is a fibrin-specific thrombolytic agent, converting plasminogen to [...]

Selexipag

Selexipag is a selective non-prostanoid agonist of prostacyclin (IP) receptor, that stimulates the release of prostacyclin, which is responsible to induce [...]